DUBLIN, July 28, 2021--(BUSINESS WIRE)--The "Digital Dose Inhalers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Digital Dose Inhalers estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$5.5 Billion by 2027, growing at a CAGR of 13.1% over the period 2020-2027.
Metered Dose, one of the segments analyzed in the report, is projected to grow at a 12.4% CAGR to reach US$3.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Dry Powder segment is readjusted to a revised 14.3% CAGR for the next 7-year period. This segment currently accounts for a 35.7% share of the global Digital Dose Inhalers market.
The U.S. Accounts for Over 42.5% of Global Market Size in 2020, While China is Forecast to Grow at a 16.4% CAGR for the Period of 2020-2027
The Digital Dose Inhalers market in the U.S. is estimated at US$992.8 Million in the year 2020. The country currently accounts for a 42.48% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$480.1 Million in the year 2027 trailing a CAGR of 16.4% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR while Rest of European market (as defined in the study) will reach US$480.1 Million by the year 2027.
Select Competitors (Total 23 Featured) -
H&T Presspart Manufacturing Ltd.
Koninklijke Philips N.V.
Novartis International AG
Opko Health, Inc.
Sensirion AG Switzerland
Teva Pharmaceutical Industries Ltd.
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of COVID-19 and a Looming Global Recession
COVID-19 Healthcare Emergency Highlights Critical Significance of Digital Dose Inhalers
Ongoing Studies Exploring Use of Inhalers-based Therapies to Treat COVID-19
COVID-19 Pandemic Pushes Patient Compliance Linked with Inhaler-based Drug Regime
An Introduction to Digital Dose Inhalers - Smart Aids to Manage Dose Delivery for Respiratory Conditions
Metered Dose Inhalers (MDI)
Dry Powder Inhalers (DPI)
Global Market Prospects and Outlook: High Prevalence of Respiratory Diseases Keeps Digital Dose Inhalers Market in Hale & Hearty Condition
Salient Growth Drivers
Analysis by Product: Metered Dose Inhalers Occupy Commanding Share
Analysis by Type of Medication: Branded Medications Segment Hold Major Share
Regional Analysis: North America to Retain Leadership Position in Digital Dose Inhalers Market
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Digital Dose Inhaler Technology Sees Proliferation of IoT
Advantages of the IoT-Enabled Digital Dose Inhaler
Market to Gain from Ongoing R&D Emphasis on Advanced Treatments for Pulmonary Diseases
Established Role of Inhaler Therapy in Respiratory Care Augurs Well
Growing Prevalence of Asthma Provides the Perfect Platform for Market Expansion
Mounting Burden of COPD Drives Demand for Digital Dose Inhaler Technology
Dry Powder Inhalers Set to Make Big Gains
Metered Dose Inhalers Continue to Exhibit Sustained Growth Momentum
Smart Inhalers Come to the Fore
Artificial Intelligence to Add Sophistication to Inhaler Technology
New HME Method to Augment Inhaler Technology
3D Printing Seeks Role in Inhaler Manufacturing
Uptrend in Healthcare Spending to Result in Improved Opportunities
Vulnerability of Growing Geriatric Population to Respiratory Diseases Enhances Prospects for Digital Inhalers
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
For more information about this report visit https://www.researchandmarkets.com/r/s51aei
View source version on businesswire.com: https://www.businesswire.com/news/home/20210728005448/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900